Kishore Biyani and FRL booked in ₹904 crore SBI fraud case

·1 views

Kishore Biyani and his company Future Retail Limited (FRL) have been named in a case relating to alleged fraud worth ₹904 crore involving State Bank of India. The charges were registered in connection with loans extended by the bank to the retail group. Investigators allege the funds were misused, though specific details of the allegations are limited in the source report. The case adds to the legal and financial troubles previously faced by Future Group and its promoter. The developments are still under investigation and no conclusions have been reached.

Read the full story at Economic Times

This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)

Indianapolis Marathon: Live Tracking, Results and Course Map Available

Race-day information for the Indianapolis Marathon is now available through a live tracking feature, results page and course map. The resources are aimed at spectators, runners and their families who want to follow participants in real time. Organizers have made the tools accessible so that users can monitor progress along the route and check finishing times as they are posted. The source article provides only a brief description of these features, so further details about the race itself are not included.

0 comments Read more at Economic Times

BusinessEconomic Times ·

Who is Dakota Meyer? Hegseth's war hero pick

0 comments Read more at Economic Times

BusinessEconomic Times ·

Rain Expected in Seattle and Bellingham, Washington

Seattle and Bellingham in Washington state are forecast to see rainfall. The original report offers no further specifics on timing or amounts. Residents in the area may want to check local forecasts for updates.

0 comments Read more at Economic Times

BusinessEconomic Times ·

Prices of several cancer drugs to fall by up to 96% from November 9

Prices of a number of cancer medicines are set to drop by as much as 96% beginning November 9. The reduction is intended to make treatment more affordable for patients. Because the price cuts take effect on a specific date, the change is expected to have an immediate impact on the cost of these therapies. The Economic Times report covers the scale and timing of the reduction.

0 comments Read more at Economic Times